Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

NCT00693017 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Epilepsy

Interventions

DRUG: Zonisamide
DRUG: Placebo

Sponsor

Eisai Limited